Skip to main content
Erschienen in: Strahlentherapie und Onkologie 1/2019

24.08.2018 | Original Article

Dose variability in different lymph node levels during locoregional breast cancer irradiation: the impact of deep-inspiration breath hold

verfasst von: Montserrat Pazos, Alba Fiorentino, Aurélie Gaasch, Stephan Schönecker, Daniel Reitz, Christian Heinz, Maximilian Niyazi, Marciana-Nona Duma, Filippo Alongi, Claus Belka, Dr. med. Stefanie Corradini

Erschienen in: Strahlentherapie und Onkologie | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Aim of the present analysis was to evaluate the movement and dose variability of the different lymph node levels of node-positive breast cancer patients during adjuvant radiotherapy (RT) with regional nodal irradiation (RNI) in deep-inspiration breath hold (DIBH).

Methods

Thirty-five consecutive node-positive breast cancer patients treated from October 2016 to February 2018 receiving postoperative RT of the breast or chest wall including RNI of the supra-/infraclavicular lymph node levels (corresponding to levels IV, III, Rotter LN (interpectoral), and some parts of level II) were analyzed. To evaluate the lymph node level movement, a center of volume (COV) was obtained for each lymph node level for free-breathing (FB) and DIBH plans. Geometric shifts and dose differences between FB and DIBH were analyzed.

Results

A significant movement of the COV in anterior (y) and cranial (z) dimensions was observed for lymph node levels I–II and Rotter lymph nodes (p < 0.001) due to DIBH. Only minor changes in the lateral dimension (x axis) were observed, without reaching significance for levels III, IV, and internal mammary. There was a significant difference in the mean dose of level I (DIBH vs. FB: 38.2 Gy/41.3 Gy, p < 0.001) and level II (DIBH vs. FB: 45.9 Gy/47.2 Gy, p < 0.001), while there was no significant difference in level III (p = 0.298), level IV (p = 0.476), or internal mammary nodes (p = 0.471).

Conclusion

A significant movement of the axillary lymph node levels was observed during DIBH in anterior and cranial directions for node-positive breast cancer patients in comparison to FB. The movement leads to a significant dose reduction in level I and level II.
Literatur
1.
Zurück zum Zitat Overgaard M, Hansen PS, Overgaard J et al (1997) Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med 337:949–955CrossRefPubMed Overgaard M, Hansen PS, Overgaard J et al (1997) Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med 337:949–955CrossRefPubMed
2.
Zurück zum Zitat Overgaard M, Nielsen HM, Overgaard J (2007) Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 b&c randomized trials. Radiother Oncol 82:247–253CrossRefPubMed Overgaard M, Nielsen HM, Overgaard J (2007) Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 b&c randomized trials. Radiother Oncol 82:247–253CrossRefPubMed
3.
Zurück zum Zitat Ragaz J, Olivotto IA, Spinelli JJ et al (2005) Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. J Natl Cancer Inst 97:116–126CrossRefPubMed Ragaz J, Olivotto IA, Spinelli JJ et al (2005) Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. J Natl Cancer Inst 97:116–126CrossRefPubMed
4.
Zurück zum Zitat Offersen BV, Boersma LJ, Kirkove C et al (2015) ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer. Radiother Oncol 114:3–10CrossRefPubMed Offersen BV, Boersma LJ, Kirkove C et al (2015) ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer. Radiother Oncol 114:3–10CrossRefPubMed
5.
Zurück zum Zitat Budach W, Bölke E, Kammers K et al (2015) Adjuvant radiation therapy of regional lymph nodes in breast cancer—a meta-analysis of randomized trials—an update. Radiat Oncol 10:1–7CrossRef Budach W, Bölke E, Kammers K et al (2015) Adjuvant radiation therapy of regional lymph nodes in breast cancer—a meta-analysis of randomized trials—an update. Radiat Oncol 10:1–7CrossRef
7.
Zurück zum Zitat Poortmans PM, Collette S, Kirkove C et al (2015) Internal mammary and medial supraclavicular irradiation in breast cancer. N Engl J Med 373:317–327CrossRefPubMed Poortmans PM, Collette S, Kirkove C et al (2015) Internal mammary and medial supraclavicular irradiation in breast cancer. N Engl J Med 373:317–327CrossRefPubMed
8.
Zurück zum Zitat Hennequin C, Bossard N, Servagi-Vernat S et al (2013) Ten-year survival results of a randomized trial of irradiation of internal mammary nodes after mastectomy. Int J Radiat Oncol Biol Phys 86:860–866CrossRefPubMed Hennequin C, Bossard N, Servagi-Vernat S et al (2013) Ten-year survival results of a randomized trial of irradiation of internal mammary nodes after mastectomy. Int J Radiat Oncol Biol Phys 86:860–866CrossRefPubMed
9.
Zurück zum Zitat Cuzick J, Stewart H, Rutqvist L et al (1994) Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. J Clin Oncol 12:447–453CrossRefPubMed Cuzick J, Stewart H, Rutqvist L et al (1994) Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. J Clin Oncol 12:447–453CrossRefPubMed
10.
Zurück zum Zitat Darby SC, Ewertz M, Mcgale P et al (2013) Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med 368:987–998CrossRefPubMed Darby SC, Ewertz M, Mcgale P et al (2013) Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med 368:987–998CrossRefPubMed
11.
Zurück zum Zitat Henson KE, Mcgale P, Taylor C et al (2013) Radiation-related mortality from heart disease and lung cancer more than 20 years after radiotherapy for breast cancer. Br J Cancer 108:179–182CrossRefPubMed Henson KE, Mcgale P, Taylor C et al (2013) Radiation-related mortality from heart disease and lung cancer more than 20 years after radiotherapy for breast cancer. Br J Cancer 108:179–182CrossRefPubMed
12.
Zurück zum Zitat Darby SC, Mcgale P, Taylor CW et al (2005) Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300,000 women in US SEER cancer registries. Lancet Oncol 6:557–565CrossRefPubMed Darby SC, Mcgale P, Taylor CW et al (2005) Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300,000 women in US SEER cancer registries. Lancet Oncol 6:557–565CrossRefPubMed
13.
Zurück zum Zitat Schonecker S, Walter F, Freislederer P et al (2016) Treatment planning and evaluation of gated radiotherapy in left-sided breast cancer patients using the CatalystTM/SentinelTM system for deep inspiration breath-hold (DIBH). Radiat Oncol 11:143CrossRefPubMedPubMedCentral Schonecker S, Walter F, Freislederer P et al (2016) Treatment planning and evaluation of gated radiotherapy in left-sided breast cancer patients using the CatalystTM/SentinelTM system for deep inspiration breath-hold (DIBH). Radiat Oncol 11:143CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Cozzi L, Lohr F, Fogliata A et al (2017) Critical appraisal of the role of volumetric modulated arc therapy in the radiation therapy management of breast cancer. Radiat Oncol 12:200CrossRefPubMedPubMedCentral Cozzi L, Lohr F, Fogliata A et al (2017) Critical appraisal of the role of volumetric modulated arc therapy in the radiation therapy management of breast cancer. Radiat Oncol 12:200CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Sachdev S, Goodman CR, Neuschler E et al (2017) Radiotherapy of MRI-detected involved internal mammary lymph nodes in breast cancer. Radiat Oncol 12:199CrossRefPubMedPubMedCentral Sachdev S, Goodman CR, Neuschler E et al (2017) Radiotherapy of MRI-detected involved internal mammary lymph nodes in breast cancer. Radiat Oncol 12:199CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Becker-Schiebe M, Stockhammer M, Hoffmann W et al (2016) Does mean heart dose sufficiently reflect coronary artery exposure in left-sided breast cancer radiotherapy? Strahlenther Onkol 192:624–631CrossRefPubMed Becker-Schiebe M, Stockhammer M, Hoffmann W et al (2016) Does mean heart dose sufficiently reflect coronary artery exposure in left-sided breast cancer radiotherapy? Strahlenther Onkol 192:624–631CrossRefPubMed
18.
Zurück zum Zitat Mast ME, Heijenbrok MW, Van Kempen-Harteveld ML et al (2016) Less increase of CT-based calcium scores of the coronary arteries: effect three years after breast-conserving radiotherapy using breath-hold. Strahlenther Onkol 192:696–704CrossRefPubMed Mast ME, Heijenbrok MW, Van Kempen-Harteveld ML et al (2016) Less increase of CT-based calcium scores of the coronary arteries: effect three years after breast-conserving radiotherapy using breath-hold. Strahlenther Onkol 192:696–704CrossRefPubMed
19.
Zurück zum Zitat Lu HM, Cash E, Chen MH et al (2000) Reduction of cardiac volume in left-breast treatment fields by respiratory maneuvers: a CT study. Int J Radiat Oncol Biol Phys 47:895–904CrossRefPubMed Lu HM, Cash E, Chen MH et al (2000) Reduction of cardiac volume in left-breast treatment fields by respiratory maneuvers: a CT study. Int J Radiat Oncol Biol Phys 47:895–904CrossRefPubMed
20.
Zurück zum Zitat Shah C, Badiyan S, Berry S et al (2014) Cardiac dose sparing and avoidance techniques in breast cancer radiotherapy. Radiother Oncol 112:9–16CrossRefPubMed Shah C, Badiyan S, Berry S et al (2014) Cardiac dose sparing and avoidance techniques in breast cancer radiotherapy. Radiother Oncol 112:9–16CrossRefPubMed
21.
Zurück zum Zitat Chen MH, Cash EP, Danias PG et al (2002) Respiratory maneuvers decrease irradiated cardiac volume in patients with left-sided breast cancer. J Cardiovasc Magn Reson 4:265–271CrossRefPubMed Chen MH, Cash EP, Danias PG et al (2002) Respiratory maneuvers decrease irradiated cardiac volume in patients with left-sided breast cancer. J Cardiovasc Magn Reson 4:265–271CrossRefPubMed
22.
Zurück zum Zitat Borm KJ, Oechsner M, Combs SE et al (2018) Deep-inspiration breath-hold radiation therapy in breast cancer: a word of caution on the dose to the axillary lymph node levels. Int J Radiat Oncol Biol Phys 100:263–269CrossRefPubMed Borm KJ, Oechsner M, Combs SE et al (2018) Deep-inspiration breath-hold radiation therapy in breast cancer: a word of caution on the dose to the axillary lymph node levels. Int J Radiat Oncol Biol Phys 100:263–269CrossRefPubMed
23.
Zurück zum Zitat Giuliano AE, Hunt KK, Ballman KV et al (2011) Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA 305:569–575CrossRefPubMedPubMedCentral Giuliano AE, Hunt KK, Ballman KV et al (2011) Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA 305:569–575CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Alongi F, Ricchetti F, Fiorentino A et al (2014) Postoperative breast radiotherapy after neoadjuvant chemotherapy: which uncertainties still remain? Tumori 100:e212–213CrossRefPubMed Alongi F, Ricchetti F, Fiorentino A et al (2014) Postoperative breast radiotherapy after neoadjuvant chemotherapy: which uncertainties still remain? Tumori 100:e212–213CrossRefPubMed
25.
Zurück zum Zitat Mamounas EP (2015) Impact of neoadjuvant chemotherapy on locoregional surgical treatment of breast cancer. Ann Surg Oncol 22:1425–1433CrossRefPubMed Mamounas EP (2015) Impact of neoadjuvant chemotherapy on locoregional surgical treatment of breast cancer. Ann Surg Oncol 22:1425–1433CrossRefPubMed
27.
Zurück zum Zitat Wenz F, Budach W (2017) Personalized radiotherapy for invasive breast cancer in 2017: national S3 guidelines and DEGRO and AGO recommendations. Strahlenther Onkol 193:601–603CrossRefPubMed Wenz F, Budach W (2017) Personalized radiotherapy for invasive breast cancer in 2017: national S3 guidelines and DEGRO and AGO recommendations. Strahlenther Onkol 193:601–603CrossRefPubMed
28.
29.
Zurück zum Zitat Mccormick B, Botnick M, Hunt M et al (2002) Are the axillary lymph nodes treated by standard tangent breast fields? J Surg Oncol 81:12–16CrossRefPubMed Mccormick B, Botnick M, Hunt M et al (2002) Are the axillary lymph nodes treated by standard tangent breast fields? J Surg Oncol 81:12–16CrossRefPubMed
30.
Zurück zum Zitat Aguiar A, Gomes Pereira H, Azevedo I et al (2015) Evaluation of axillary dose coverage following whole breast radiotherapy: variation with the breast volume and shape. Radiother Oncol 114:22–27CrossRefPubMed Aguiar A, Gomes Pereira H, Azevedo I et al (2015) Evaluation of axillary dose coverage following whole breast radiotherapy: variation with the breast volume and shape. Radiother Oncol 114:22–27CrossRefPubMed
31.
Zurück zum Zitat Reed DR, Lindsley SK, Mann GN et al (2005) Axillary lymph node dose with tangential breast irradiation. Int J Radiat Oncol Biol Phys 61:358–364CrossRefPubMed Reed DR, Lindsley SK, Mann GN et al (2005) Axillary lymph node dose with tangential breast irradiation. Int J Radiat Oncol Biol Phys 61:358–364CrossRefPubMed
32.
Zurück zum Zitat Russo JK, Armeson KE, Rhome R et al (2011) Dose to level I and II axillary lymph nodes and lung by tangential field radiation in patients undergoing postmastectomy radiation with tissue expander reconstruction. Radiat Oncol 6:179CrossRefPubMedPubMedCentral Russo JK, Armeson KE, Rhome R et al (2011) Dose to level I and II axillary lymph nodes and lung by tangential field radiation in patients undergoing postmastectomy radiation with tissue expander reconstruction. Radiat Oncol 6:179CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat Zhang L, Yang ZZ, Chen XX et al (2015) Dose coverage of axillary level I–III areas during whole breast irradiation with simplified intensity modulated radiation therapy in early stage breast cancer patients. Oncotarget 6:18183–18191PubMedPubMedCentral Zhang L, Yang ZZ, Chen XX et al (2015) Dose coverage of axillary level I–III areas during whole breast irradiation with simplified intensity modulated radiation therapy in early stage breast cancer patients. Oncotarget 6:18183–18191PubMedPubMedCentral
34.
Zurück zum Zitat Haffty BG, Hunt KK, Harris JR et al (2011) Positive sentinel nodes without axillary dissection: implications for the radiation oncologist. J Clin Oncol 29:4479–4481CrossRefPubMed Haffty BG, Hunt KK, Harris JR et al (2011) Positive sentinel nodes without axillary dissection: implications for the radiation oncologist. J Clin Oncol 29:4479–4481CrossRefPubMed
35.
Zurück zum Zitat Donker M, Van Tienhoven G, Straver ME et al (2014) Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981–22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial. Lancet Oncol 15:1303–1310CrossRefPubMedPubMedCentral Donker M, Van Tienhoven G, Straver ME et al (2014) Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981–22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial. Lancet Oncol 15:1303–1310CrossRefPubMedPubMedCentral
36.
Zurück zum Zitat Okunieff P, Morgan D, Niemierko A et al (1995) Radiation dose-response of human tumors. Int J Radiat Oncol Biol Phys 32:1227–1237CrossRefPubMed Okunieff P, Morgan D, Niemierko A et al (1995) Radiation dose-response of human tumors. Int J Radiat Oncol Biol Phys 32:1227–1237CrossRefPubMed
Metadaten
Titel
Dose variability in different lymph node levels during locoregional breast cancer irradiation: the impact of deep-inspiration breath hold
verfasst von
Montserrat Pazos
Alba Fiorentino
Aurélie Gaasch
Stephan Schönecker
Daniel Reitz
Christian Heinz
Maximilian Niyazi
Marciana-Nona Duma
Filippo Alongi
Claus Belka
Dr. med. Stefanie Corradini
Publikationsdatum
24.08.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
Strahlentherapie und Onkologie / Ausgabe 1/2019
Print ISSN: 0179-7158
Elektronische ISSN: 1439-099X
DOI
https://doi.org/10.1007/s00066-018-1350-y

Weitere Artikel der Ausgabe 1/2019

Strahlentherapie und Onkologie 1/2019 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.